Literature DB >> 19591526

Medication problems in older, newly diagnosed cancer patients in Canada: How common are they? A prospective pilot study.

Martine T E Puts1, Beatriz Costa-Lima, Johanne Monette, Veronique Girre, Christina Wolfson, Gerald Batist, Howard Bergman.   

Abstract

BACKGROUND: Prescribing for older patients is challenging and complex. Cancer patients are at a considerable increased risk of drug-related problems because they typically receive a large number of medications during their cancer treatment, both for the cancer itself and for supportive care. Few studies have examined the scope of this problem in older newly diagnosed cancer patients.
OBJECTIVE: To investigate the number and severity of potential drug problems and factors associated with the occurrence of potential drug problems in older newly diagnosed cancer patients.
METHODS: This prospective pilot study was conducted in newly diagnosed cancer patients aged > or =65 years recruited in the Segal Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada. Vigilance Santé software was used to identify the presence and type of potential drug problems. Logistic regression analyses were used to identify factors associated with the presence of one or more severe or moderately severe potential drug problems.
RESULTS: There were 112 participants with a mean age of 74.2 years, and 70% were women. A total of 103 patients (92%) were taking medications. The median number of medications per patient was 5 (interquartile range 3-9) and a total of 247 potential drug problems were identified. Sixty-four patients (62.1%) had a potential drug problem of any level of severity and 49 patients had a potential moderate/severe drug problem identified (47.6%). Two (0.8%) potential drug problems of the most severe level were identified, 122 warnings (49.4%) of all potential problems were of moderate severity and 123 warnings (49.8%) were at the least severe level. Factors associated with having one or more moderate/severe potential drug problems were taking five or more drugs and age > or =76 years.
CONCLUSION: The majority of older newly diagnosed cancer patients in this study were taking at least one medication and the median number of medications per patient was 5. Published studies have shown that medication problems are common in community-dwelling older persons, but they are mostly of low severity. In this group of older newly diagnosed cancer patients, potential medication problems were also found to be common; however, half of the potential problems identified were of moderate severity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591526     DOI: 10.2165/00002512-200926060-00008

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  55 in total

Review 1.  Medication non-adherence among older adults: a review of strategies and interventions for improvement.

Authors:  Elizabeth A Schlenk; Jacqueline Dunbar-Jacob; Sandra Engberg
Journal:  J Gerontol Nurs       Date:  2004-07       Impact factor: 1.254

Review 2.  A systematic review on drug interactions in oncology.

Authors:  Rachel P Riechelmann; Everardo D Saad
Journal:  Cancer Invest       Date:  2006-11       Impact factor: 2.176

3.  Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Authors:  Kirsten K Viktil; Hege S Blix; Tron A Moger; Aasmund Reikvam
Journal:  Br J Clin Pharmacol       Date:  2006-08-30       Impact factor: 4.335

4.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Polypharmacy and prescribing quality in older people.

Authors:  Michael A Steinman; C Seth Landefeld; Gary E Rosenthal; Daniel Berthenthal; Saunak Sen; Peter J Kaboli
Journal:  J Am Geriatr Soc       Date:  2006-10       Impact factor: 5.562

7.  Potentially inappropriate prescribing for the elderly: effects of geriatric care at the patient and health care system level.

Authors:  Mary Jo V Pugh; Amy K Rosen; Maria Montez-Rath; Megan E Amuan; Benjamin G Fincke; Muriel Burk; Arlene Bierman; Francesca Cunningham; Eric M Mortensen; Dan R Berlowitz
Journal:  Med Care       Date:  2008-02       Impact factor: 2.983

8.  Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly.

Authors:  Alex Z Fu; Jenny Z Jiang; Jaxk H Reeves; Jack E Fincham; Gordon G Liu; Matthew Perri
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

9.  Potential drug interactions and duplicate prescriptions among cancer patients.

Authors:  Rachel P Riechelmann; Ian F Tannock; Lisa Wang; Everardo D Saad; Nathan A Taback; Monika K Krzyzanowska
Journal:  J Natl Cancer Inst       Date:  2007-04-18       Impact factor: 13.506

10.  Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.

Authors:  C McCowan; J Shearer; P T Donnan; J A Dewar; M Crilly; A M Thompson; T P Fahey
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

View more
  22 in total

1.  Senior adult oncology.

Authors:  Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

Review 2.  Elderly acute myeloid leukemia: assessing risk.

Authors:  Heidi D Klepin
Journal:  Curr Hematol Malig Rep       Date:  2015-06       Impact factor: 3.952

3.  Potential drug interactions in patients with a history of cancer.

Authors:  L Chen; W Y Cheung
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

4.  The prognostic importance of polypharmacy in older adults treated for acute myelogenous leukemia (AML).

Authors:  Kathleen Elliot; Janet A Tooze; Rachel Geller; Bayard L Powell; Timothy S Pardee; Ellen Ritchie; LeAnne Kennedy; Kathryn E Callahan; Heidi D Klepin
Journal:  Leuk Res       Date:  2014-07-07       Impact factor: 3.156

Review 5.  Application of drug-related problem (DRP) classification systems: a review of the literature.

Authors:  Benjamin J Basger; Rebekah J Moles; Timothy F Chen
Journal:  Eur J Clin Pharmacol       Date:  2014-05-02       Impact factor: 2.953

Review 6.  Polypharmacy in the Geriatric Oncology Population.

Authors:  Lauren R Hersh; Kathryn Beldowski; Emily R Hajjar
Journal:  Curr Oncol Rep       Date:  2017-09-23       Impact factor: 5.075

7.  Polypharmacy and the management of the older cancer patient.

Authors:  L Balducci; D Goetz-Parten; M A Steinman
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

Review 8.  A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.

Authors:  Andrew M Whitman; Kathlene A DeGregory; Amy L Morris; Erika E Ramsdale
Journal:  Oncologist       Date:  2016-05-05

9.  Potential medication problems in older newly diagnosed cancer patients in Canada during cancer treatment: a prospective pilot cohort study.

Authors:  Martine T E Puts; Johanne Monette; Veronique Girre; Beatriz Costa-Lima; Christina Wolfson; Gerald Batist; Howard Bergman
Journal:  Drugs Aging       Date:  2010-07-01       Impact factor: 3.923

10.  Prevalence and factors associated with polypharmacy in older people with cancer.

Authors:  Justin P Turner; Sepehr Shakib; Nimit Singhal; Jonathon Hogan-Doran; Robert Prowse; Sally Johns; J Simon Bell
Journal:  Support Care Cancer       Date:  2014-03-02       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.